These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 16909495)

  • 1. Inquiries in Britain uncover loopholes in drug trials.
    Rosenthal E
    N Y Times Web; 2006 Aug; ():A3. PubMed ID: 16909495
    [No Abstract]   [Full Text] [Related]  

  • 2. One drug, six men, disaster..
    Bhattacharya S; Coghlan A
    New Sci; 2006 Mar 25-31; 189(2544):10-1. PubMed ID: 16832959
    [No Abstract]   [Full Text] [Related]  

  • 3. Does the TGN1412 trial disaster have lessons for clinical trials in India?
    George T; Srinivasan S
    Natl Med J India; 2006; 19(5):283-6. PubMed ID: 17203685
    [No Abstract]   [Full Text] [Related]  

  • 4. British rethinking test rules after drug trial nearly kills 6.
    Rosenthal E
    N Y Times Web; 2006 Apr; ():A1, A6. PubMed ID: 16642579
    [No Abstract]   [Full Text] [Related]  

  • 5. Agency criticises drug trial.
    Day M
    BMJ; 2006 Jun; 332(7553):1290. PubMed ID: 16740539
    [No Abstract]   [Full Text] [Related]  

  • 6. [Why has the drug trial at Northwick Park Hospital turned out to a disaster?].
    Lafolie P
    Lakartidningen; 2006 Apr 12-25; 103(15-16):1169-70. PubMed ID: 16696196
    [No Abstract]   [Full Text] [Related]  

  • 7. Urgent changes needed for authorisation of phase I trials.
    Lancet; 2006 Apr; 367(9518):1214. PubMed ID: 16631859
    [No Abstract]   [Full Text] [Related]  

  • 8. Severe adverse reactions prompt call for trial design changes.
    Mayor S
    BMJ; 2006 Mar; 332(7543):683. PubMed ID: 16565101
    [No Abstract]   [Full Text] [Related]  

  • 9. TGN1412: time to change the paradigm for the testing of new pharmaceuticals.
    Bhogal N; Combes R
    Altern Lab Anim; 2006 May; 34(2):225-39. PubMed ID: 16704293
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Relatively good safety in Swedish phase I trials. A survey of studies reported to the Medical Products Agency during 3 years].
    Glazer A; Hedenmalm K
    Lakartidningen; 2008 Sep 10-16; 105(37):2482-4. PubMed ID: 19006863
    [No Abstract]   [Full Text] [Related]  

  • 11. Commentary on the EMA Guideline on strategies to identify and mitigate risks for first-in-human and early clinical trials with investigational medicinal products.
    van Gerven J; Bonelli M
    Br J Clin Pharmacol; 2018 Jul; 84(7):1401-1409. PubMed ID: 29451320
    [No Abstract]   [Full Text] [Related]  

  • 12. Learning from the TGN1412 trial.
    Goodyear M
    BMJ; 2006 Mar; 332(7543):677-8. PubMed ID: 16554332
    [TBL] [Abstract][Full Text] [Related]  

  • 13. London's disastrous drug trial has serious side effects for research.
    Wadman M
    Nature; 2006 Mar; 440(7083):388-9. PubMed ID: 16554763
    [No Abstract]   [Full Text] [Related]  

  • 14. Britain adopts more stringent rules for phase I trials of high-risk compounds.
    Sinha G
    J Natl Cancer Inst; 2007 Jun; 99(12):915-7. PubMed ID: 17565146
    [No Abstract]   [Full Text] [Related]  

  • 15. The elephant in the room.
    Nature; 2006 Dec; 444(7121):790. PubMed ID: 17167433
    [No Abstract]   [Full Text] [Related]  

  • 16. In drug research, some guinea pigs are now human.
    Pollack A
    N Y Times Web; 2004 Aug; ():A1, C3. PubMed ID: 15497234
    [No Abstract]   [Full Text] [Related]  

  • 17. Comparative requirements for exploratory clinical trials -- eIND, eCTA and microdosing.
    Muller PY
    Adv Drug Deliv Rev; 2011 Jun; 63(7):511-7. PubMed ID: 21034787
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Why wasn't an investigational new drug (IND) application required before appropriate study?
    Maloney DM
    Hum Res Rep; 2004 Mar; 19(3):6-7. PubMed ID: 15139342
    [No Abstract]   [Full Text] [Related]  

  • 19. Patients in test won't get drug, Amgen decides.
    Pollack A
    N Y Times Web; 2005 Feb; ():C1, C2. PubMed ID: 15742509
    [No Abstract]   [Full Text] [Related]  

  • 20. TGN1412: the catalyst for change?
    Altern Lab Anim; 2006 Aug; 34(4):369-71. PubMed ID: 16969950
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.